Immunological Evidence for Deficiency in an Activator Protein for Sulfatide Sulfatase in a Variant Form of Metachromatic Leukodystrophy.

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.80.10.3074
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Metachromatic Leukodystrophy

2020English

Classical Case of Late-Infantile Form of Metachromatic Leukodystrophy

Journal of Neurosciences in Rural Practice
NeuroscienceNeurology
2016English

Metachromatic Leukodystrophy: Two Sides of a Coin.

BMJ
1993English

Molecular Bases of Metachromatic Leukodystrophy in Polish Patients

Journal of Human Genetics
Genetics
2010English

Deficiency of the Hexosaminidase a Activator Protein in a Case of GM2 Gangliosidosis; Variant AB

Pediatric Research
Child HealthPediatricsPerinatology
1982English

A Novel Mutation of the Arylsulfatase a Gene in Late-Onset Metachromatic Leukodystrophy

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2009English

Synthetic Sulfogalactosylceramide (Sulfatide) and Its Use for the Mass Spectrometric Quantitative Urinary Determination in Metachromatic Leukodystrophies

Glycoconjugate Journal
BiochemistryCell BiologyMolecular Biology
2007English

Induction of Tolerance to Human Arylsulfatase a in a Mouse Model of Metachromatic Leukodystrophy

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2007English

880. Hematopoietic Stem Cell Gene Therapy for the Treatment of Metachromatic Leukodystrophy: Clinical Trial Design

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy